Skip to main content
Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: Gradual increasing dyslipidemia in treatment-naive male patients with human immunodeficiency virus and treated with tenofovir plus lamivudine plus efavirenz for 3 years

Fig. 2

Long-term dynamic changes in anthropometric parameters over 144 weeks after initial ART with TDF plus 3TC plus EFV in treatment-naive patients with HIV (n = 61). A Body weight. B Body nonfat weight. C Body mass index. D Body fat weight. E Body fat percentage. ART, active antiretroviral therapy. TDF, Tenofovir. 3TC, Lamivudine. EFV, Efavirenz. ANOVA was used to compare anthropometric parameters from baseline to 144 weeks, and a paired t-test was used to compare anthropometric parameters between baseline and some follow-up time points. Comparison between different time points and compared with baseline, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us